The pharmaceutical sector in the world has experienced an unprecedented expansion in different aspects, mainly in the increase of access to health care worldwide in the last ten years, of hundreds of millions of people in low and middle income countries who obtain access through government programs,
Molecular complexity is one of the differences between biological drugs and conventional chemicals, the molecules of a biopharmaceutical are much heavier, have a more complex spatial structure and are more diverse than the small molecules that make up conventional medicines, a molecule of A biological medicine is a protein formed by a chain of hundreds of amino acids with a three-dimensional structure that will affect its activity.
Biosimilars allow a greater number of patients to access high quality treatments with proven safety and efficacy profiles, our company is committed to the development and production of innovative treatments based on our experience to reach more patients with serious illnesses, Biosimilars will help maintain the commitment to connect patients with essential medicines.
We work for the welfare of society and to increase the quality of life and assistance to patients affected by serious diseases, allowing access to specialized medicines and innovation that allow them to access technological development to patients with a decrease in the cost of Medical treatments.
It is one of the youngest biopharmaceutical companies with a projection of high profitability and rapid growth in Colombia, with several products in process, oncological medicines for different applications, which makes us a promising player in the generic drugs against cancer.